Telix Pharmaceuticals Ltd
ASX:TLX
Telix Pharmaceuticals Ltd
Net Income (Common)
Telix Pharmaceuticals Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Net Income (Common)
AU$5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immutep Ltd
ASX:IMM
|
Net Income (Common)
-AU$40.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-12%
|
|
Mesoblast Ltd
ASX:MSB
|
Net Income (Common)
-$73.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Net Income (Common)
$2.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Net Income (Common)
AU$30.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Net Income (Common)
-AU$21.6m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-23%
|
See Also
What is Telix Pharmaceuticals Ltd's Net Income (Common)?
Net Income (Common)
5.2m
AUD
Based on the financial report for Dec 31, 2023, Telix Pharmaceuticals Ltd's Net Income (Common) amounts to 5.2m AUD.